A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment
Public ClinicalTrials.gov record NCT04635111. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Long-term Study to Further Evaluate the Risk of Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment
Study identification
- NCT ID
- NCT04635111
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Daiichi Sankyo
- Industry
- Enrollment
- 30 participants
Conditions and interventions
Conditions
Interventions
- TURALIO™ Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 6, 2021
- Primary completion
- May 31, 2036
- Completion
- May 31, 2036
- Last update posted
- Oct 5, 2025
2021 – 2036
United States locations
- U.S. sites
- 8
- U.S. states
- 5
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Kamalesh K Sankhala MD INC | Santa Monica | California | 90403 | Recruiting |
| Sarcoma Oncology Research Center LLC | Santa Monica | California | 90403 | Not yet recruiting |
| UCLA Hematology and Oncology | Santa Monica | California | 90404 | Recruiting |
| The Oncology Institute of Hope and Innovation | Whittier | California | 90602 | Withdrawn |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | Recruiting |
| Montefiore Medical Center | New York | New York | 10467 | Withdrawn |
| OSU - James Comprehensive Cancer Center | Columbus | Ohio | 43210 | Recruiting |
| Kelsey Seybold Clinic - Pearland | Houston | Texas | 77014 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04635111, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 5, 2025 · Synced May 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04635111 live on ClinicalTrials.gov.